Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new Review, published in the Lancet, analyses the use of placebo controls in surgery and offers a practical checklist for researchers designing trials.

Surgeon operating

Placebo comparisons are universally used in randomised controlled trials as a critical way to measure the safety and efficacy of new drugs and treatments. But increasingly, placebo controls are being used to assess surgical interventions, raising questions around ethics, risk to patients, and whether their design adds to scientific knowledge.

"The placebo used to evaluate a surgical intervention might involve close replication of the normal surgery, but may have some (or all) of the theoretically beneficial aspects taken away." said David Beard, Professor of Musculoskeletal and Surgical Science at NDORMS. "This is a relatively new, and sometimes controversial, way of evaluating surgery with some special considerations. Placebo interventions have all the potential risks of surgery (which thankfully are low) but with fewer perceived benefits - the methodology and ethical considerations for any such trial are therefore very important. We were keen to provide an up-to-date knowledge resource on all aspects of their use for the ongoing evaluation of some surgical procedures."

The Review, Considerations and methods for placebo controls in surgical trials, outlines what a placebo control entails and explains the present understanding of this approach in the context of surgery. It considers when placebo controls in surgery are acceptable (and when they are desirable) in terms of ethical arguments and regulatory requirements, how a placebo control should be designed, how to identify and mitigate risk for participants in these trials, and how such trials should be done and interpreted.

The work culminated in the production of practical guidance for researchers: Applying Surgical Placebo in Randomised Evaluations (ASPIRE). The ASPIRE guidelines are designed as a checklist for researchers to ensure that surgical placebo controls in randomised trials meet quality standards in rationale and ethics, design, conduct, and interpretation.

The insights in the Review are mainly based on the outputs of a workshop funded by the UK's National Institute of Health Research and Medical Research Council, which brought together an international team of interdisciplinary experts with research experience in placebo surgery and patients. The workshop included a systematic update of important literature, an in depth discussion of case studies, and an explanation of direct experience and best practice.

The Review concludes that surgical placebo controls in RCTs are not appropriate for all evaluations of surgery. They might be best reserved for operations associated with low surgical complication risk, potentially low efficacy, unjustified usage, and in which a clinically significant placebo response is expected. "In expectation of a complex set of ethical issues, these trials need to have the greatest possible chance of answering the primary research question in a robust manner," said David. "Using the ASPIRE checklist, researchers can ensure they design trials that reach a minimum standard and mitigate any risks associated with the placebo surgical control."

Similar stories

NIHR Fellowships awarded to NDORMS researchers

Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships

ORUK Early Career Research Fellowship awarded to NDORMS researcher

Congratulations to Jack Tu who has been awarded an Orthopaedic Research UK Early Career Research Fellowship to explore the cause of knee pain after total knee replacement.

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report

Unhelpful thoughts about fracture symptoms hinder recovery

The importance of mindsets and feelings about fracture symptoms have been shown to be a key factor in recovery of musculoskeletal conditions.

Fat tissues can play a protective role against inflammation in the intestine

A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.

NDORMS researchers awarded Sir Henry Wellcome Fellowships

Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.